Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug
use in pregnancy is developing in an area of clinical uncertainty. Although many studies …

Background Prenatal depression affects∼ 12% of pregnant women in the United States and
is associated with an increased risk of adverse birth outcomes and maternal mortality …

Psychiatric and obstetric diseases are growing threats to public health and share high rates
of co-morbidity. G protein-coupled receptor signaling (eg, vasopressin, serotonin) may be a …

Objectives Preeclampsia and depression in pregnancy are among the most prevalent
obstetric disorders with no known cures. While depression and preeclampsia each increase …

Gestational exposures have enduring impacts on brain and neuroimmune development and
function. Perturbations of pregnancy leading to placental structure/function deficits, cell …

Background: The need for antidepressants during pregnancy is significant, considering the
prevalence of diseases such as prenatal depression and perinatal anxiety among pregnant …

Introduction: Adverse childhood experiences (ACEs) are a measure of childhood adversity
and are associated with life-long morbidity. The impacts of ACEs on peripartum health …

First, our meta-analysis [1] was an updated synthesis of the primary literature and therefore
did not include secondary analyses (eg, Guean et al.).[2] Prior work found modest risk ratios …